Frequently relapsing steroid-sensitive idiopathic nephrotic syndrome in children: Its treatment with levamisole;Die behandlung des haufig rezidivierenden steroidsensiblen idiopathischen nephrotischen syndroms im kindesalter mit levamisol

Deutsche Medizinische Wochenschrift

Volumn 123, Issue 9, 1998, Pages 239-243

  Kemper, M J ^a   Amon, O ^a   Timmermann, Kirsten ^a   Altrogge, H ^a   Muller Wiefel D E ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; LEVAMISOLE; STEROID; CYCLOSPORIN; IMMUNOLOGICAL ADJUVANT; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG WITHDRAWAL; EPIGASTRIC PAIN; FEMALE; HUMAN; IDIOPATHIC DISEASE; LEUKOPENIA; MALE; NEPHROTIC SYNDROME; ORAL DRUG ADMINISTRATION; RASH; RELAPSE; STEROID THERAPY; PRESCHOOL CHILD; RECURRENT DISEASE;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEVAMISOLE; MALE; NEPHROTIC SYNDROME; RECURRENCE; STEROIDS;

EID: 0032570330     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1023943     Document Type: Article

References (27)

1. Anonymus: Levamisole for childhood nephrotic syndrome. Lancet 337 (1991), 1574.
2. Arbeitsgemeinschaft für Pädiatrische Nephrologie: Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependency. New Engl. J. Med. 306 (1982), 451.
3. Bagga, A. et al.: Levamisole therapy in corticosteroid dependent nephrotic syndrome. Pediat. Nephrol. 11 (1997), 415-417.
4. Barratt, T. M., A. Bercowsky et al.: Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood. Lancet 1/1975, 55-58.
5. Barrat, T. M., G. Clark: Minimal change nephrotic syndrome and focal segmental glomerulosclerosis. In Holliday, M. A., T. M. Barrat, E. D. Avner (Ed.): Pediatric Nephrology (Williams & Wilkins: Baltimore, 1994), 767-787.
6. British Association of Paediatric Nephrology: Levamisole for corticosteroid dependent nephrotic syndrome in childhood. Lancet 337 (1991), 1555-1557.
7. Brodehl, J.: The treatment of minimal change nephrotic syndrome. Europ. J. Pediat. 150 (1991), 380-387.
8. Dayal, U., A. K. Dayal, J. C. M. Shastry, P. Raghupathy: Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children. Nephron 66 (1994), 408-412.
9. Drachman, R., M. Schlesinger, U. Alon, J. Mor: Immunoregulation with levamisole in children with frequently relapsing nephrotic syndrome. Acta paediat. scand. 77 (1988), 721-726.
10. Hoyer, P. F.: Aktuelle Therapie des steroidsensiblen nephrotischen Syndroms im Kindesalter. Kinderarzt 25 (1994), 946-955.
11. Hulton, S. A., T.J. Neuhaus, M.J. Dillon, T. M. Barratt: Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood. Pediat. Nephrol. 8 (1994), 401-403.
12. International Study of Kidney Diseases in Children: Early identification of frequent relapsers among children with minimal change nephrotic syndrome. J. Pediat. 101 (1982), 514-518.
13. Konrad, M., J. Mytilineos, H. Ruder, G. Opelz, K. Schärer: HLA-DR7 predicts the response to alkylating agents in steroid-sensitive nephrotic syndrome. Pediat. Nephrol. 11 (1997), 16-19.
14. Mancini, M. L., S. Rinaldi, G. Rizzoni: Treatment of partially corticosteroid-sensitive nephrotic syndrome with levamisole. Pediatr. Nephrol. 8 (1994), 788.
15. Mehta, K. P., U. Ali et al.: Immunoregulatory treatment for minimal change nephrotic syndrome. Arch. Dis. Childh. 61 (1986), 153-158.
16. Meregalli, P., M. G. Bianchetti, G. Imoberdorf et al.: Levamisol bei Kindern mit häufig rezidivierendem nephrotischem Syndrom. Schweiz. med. Wschr. 124 (1994), 801-805.
17. Mongeau, J. G., P. O. Robitaille, F. Roy: Clinical efficacy of levamisole for corticosteroid-dependent treatment of nephrosis in children. Pediat. Nephrol. 2 (1988), 398-401.
18. Neuhaus, T.J., J. Fay, M. J. Dillon, R. S. Trompeter, T. M. Barratt: Alternative treatment to corticosteroids in steroid sensitive idiopathic nephrotic syndrome. Arch. Dis. Childh. 71 (1994), 522-526.
19. Niaudet, P., R. Drachman et al.: Treatment of idiopathic nephrotic syndrome with levamisole. Acta paediat. scand. 73 (1984), 637-641.
20. Niaudet, P., R. Habib: Cyclosporine in the treatment of idiopathic nephrosis. J. Amer. Soc. Nephrol. 5 (1994), 1049-1056.
21. Report of a workshop by the British Association of Paediatric Nephrology and Research Unit, Royal College of Physicians: Consensus statement on management and audit potential for steroid responsive nephrotic syndrome. Arch. Dis. Childh. 70 (1994), 151.
22. Report of the Arbeitsgemeinschaft für Pädiatrische Nephrologie: Cyclophosphamide treatment of steroid dependent nephrotic syndrome. Arch. Dis. Childh. 62 (1987), 1102-1106.
23. Schnaper, H. W.: The immune system in idiopathic childhood nephrotic syndrome. Pediat. Nephrol. 13 (1989), 101-110.
24. Tanphaichitr, P., V. Boonpucknavig et al.: The nephrotic syndrome of childhood in Thailand. J. Trop. Med. 20 (1974), 112-121.
25. Tenbrock, K., J. Müller Berghaus, A. Fuchshuber, U. Querfeld, D. Michalk: Therapie des idiopathischen nephrotischen Syndroms mit Levamisol. Mschr. Kinderheilk. 145 (1997), 209.
26. Ueda, N., K. Kuno, S. Ito: 8 and 12 week course of cyclophosphamide in nephrotic syndrome. Arch. Dis. Childh. 65 (1990), 1147.
27. Van Wauwe, J., P. A. J. Jansen: On the biochemical mode of action of levamisole: an Update. Int. J. Immunopharmacol. 13 (1991), 3-9.